# A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers

> **NCT06085781** · NA · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 60 (estimated)

## Conditions studied

- Squamous Cell Carcinoma of Head and Neck

## Interventions

- **OTHER:** fMRI
- **OTHER:** Oral Pimonidazole

## Key facts

- **NCT ID:** NCT06085781
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-29
- **Primary completion:** 2027-01-15
- **Final completion:** 2027-01-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06085781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06085781, "A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06085781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*